Global AI-Powered Drug Discovery Software Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01246465

Publication Date:

January 11, 2024

Pages:

126

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global AI-Powered Drug Discovery Software market size was valued at US$ million in 2023. With growing demand in downstream market, the AI-Powered Drug Discovery Software is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI-Powered Drug Discovery Software market. AI-Powered Drug Discovery Software are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI-Powered Drug Discovery Software. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI-Powered Drug Discovery Software market.
AI-Powered Drug Discovery Software is a software system that uses artificial intelligence technology for drug discovery and development. It uses advanced artificial intelligence algorithms and technologies such as machine learning, deep learning, and data mining to help drug researchers perform data analysis, prediction, and optimization during the drug discovery process.
Key Features:
The report on AI-Powered Drug Discovery Software market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AI-Powered Drug Discovery Software market. It may include historical data, market segmentation by Type (e.g., On-Premise, Cloud-Based), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI-Powered Drug Discovery Software market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI-Powered Drug Discovery Software market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI-Powered Drug Discovery Software industry. This include advancements in AI-Powered Drug Discovery Software technology, AI-Powered Drug Discovery Software new entrants, AI-Powered Drug Discovery Software new investment, and other innovations that are shaping the future of AI-Powered Drug Discovery Software.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI-Powered Drug Discovery Software market. It includes factors influencing customer ' purchasing decisions, preferences for AI-Powered Drug Discovery Software product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI-Powered Drug Discovery Software market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI-Powered Drug Discovery Software market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI-Powered Drug Discovery Software market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI-Powered Drug Discovery Software industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI-Powered Drug Discovery Software market.
Market Segmentation:
AI-Powered Drug Discovery Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
On-Premise
Cloud-Based
Segmentation by application
Pharmaceutical Company
Academic Research Institution
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AtomWise
AutoDock
BenevolentAI
CCD Vault
Compound Assist
Cyclica
DrugDev Spark
DrugPatentWatch
DSG Drug Safety
Epocrates
InSilicoTrials
Insilico Medicine
Micro Tracker
PEPID PDC
厂肠丑谤枚诲颈苍驳别谤
Thermo Scientific
XtalPi

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI-Powered Drug Discovery Software Market Size 2019-2030
2.1.2 AI-Powered Drug Discovery Software Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI-Powered Drug Discovery Software Segment by Type
2.2.1 On-Premise
2.2.2 Cloud-Based
2.3 AI-Powered Drug Discovery Software Market Size by Type
2.3.1 AI-Powered Drug Discovery Software Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI-Powered Drug Discovery Software Market Size Market Share by Type (2019-2024)
2.4 AI-Powered Drug Discovery Software Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Academic Research Institution
2.4.3 Others
2.5 AI-Powered Drug Discovery Software Market Size by Application
2.5.1 AI-Powered Drug Discovery Software Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI-Powered Drug Discovery Software Market Size Market Share by Application (2019-2024)
3 AI-Powered Drug Discovery Software Market Size by Player
3.1 AI-Powered Drug Discovery Software Market Size Market Share by Players
3.1.1 Global AI-Powered Drug Discovery Software Revenue by Players (2019-2024)
3.1.2 Global AI-Powered Drug Discovery Software Revenue Market Share by Players (2019-2024)
3.2 Global AI-Powered Drug Discovery Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-Powered Drug Discovery Software by Regions
4.1 AI-Powered Drug Discovery Software Market Size by Regions (2019-2024)
4.2 Americas AI-Powered Drug Discovery Software Market Size Growth (2019-2024)
4.3 APAC AI-Powered Drug Discovery Software Market Size Growth (2019-2024)
4.4 Europe AI-Powered Drug Discovery Software Market Size Growth (2019-2024)
4.5 Middle East & Africa AI-Powered Drug Discovery Software Market Size Growth (2019-2024)
5 Americas
5.1 Americas AI-Powered Drug Discovery Software Market Size by Country (2019-2024)
5.2 Americas AI-Powered Drug Discovery Software Market Size by Type (2019-2024)
5.3 Americas AI-Powered Drug Discovery Software Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-Powered Drug Discovery Software Market Size by Region (2019-2024)
6.2 APAC AI-Powered Drug Discovery Software Market Size by Type (2019-2024)
6.3 APAC AI-Powered Drug Discovery Software Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI-Powered Drug Discovery Software by Country (2019-2024)
7.2 Europe AI-Powered Drug Discovery Software Market Size by Type (2019-2024)
7.3 Europe AI-Powered Drug Discovery Software Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI-Powered Drug Discovery Software by Region (2019-2024)
8.2 Middle East & Africa AI-Powered Drug Discovery Software Market Size by Type (2019-2024)
8.3 Middle East & Africa AI-Powered Drug Discovery Software Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI-Powered Drug Discovery Software Market Forecast
10.1 Global AI-Powered Drug Discovery Software Forecast by Regions (2025-2030)
10.1.1 Global AI-Powered Drug Discovery Software Forecast by Regions (2025-2030)
10.1.2 Americas AI-Powered Drug Discovery Software Forecast
10.1.3 APAC AI-Powered Drug Discovery Software Forecast
10.1.4 Europe AI-Powered Drug Discovery Software Forecast
10.1.5 Middle East & Africa AI-Powered Drug Discovery Software Forecast
10.2 Americas AI-Powered Drug Discovery Software Forecast by Country (2025-2030)
10.2.1 United States AI-Powered Drug Discovery Software Market Forecast
10.2.2 Canada AI-Powered Drug Discovery Software Market Forecast
10.2.3 Mexico AI-Powered Drug Discovery Software Market Forecast
10.2.4 Brazil AI-Powered Drug Discovery Software Market Forecast
10.3 APAC AI-Powered Drug Discovery Software Forecast by Region (2025-2030)
10.3.1 China AI-Powered Drug Discovery Software Market Forecast
10.3.2 Japan AI-Powered Drug Discovery Software Market Forecast
10.3.3 Korea AI-Powered Drug Discovery Software Market Forecast
10.3.4 Southeast Asia AI-Powered Drug Discovery Software Market Forecast
10.3.5 India AI-Powered Drug Discovery Software Market Forecast
10.3.6 Australia AI-Powered Drug Discovery Software Market Forecast
10.4 Europe AI-Powered Drug Discovery Software Forecast by Country (2025-2030)
10.4.1 Germany AI-Powered Drug Discovery Software Market Forecast
10.4.2 France AI-Powered Drug Discovery Software Market Forecast
10.4.3 UK AI-Powered Drug Discovery Software Market Forecast
10.4.4 Italy AI-Powered Drug Discovery Software Market Forecast
10.4.5 Russia AI-Powered Drug Discovery Software Market Forecast
10.5 Middle East & Africa AI-Powered Drug Discovery Software Forecast by Region (2025-2030)
10.5.1 Egypt AI-Powered Drug Discovery Software Market Forecast
10.5.2 South Africa AI-Powered Drug Discovery Software Market Forecast
10.5.3 Israel AI-Powered Drug Discovery Software Market Forecast
10.5.4 Turkey AI-Powered Drug Discovery Software Market Forecast
10.5.5 GCC Countries AI-Powered Drug Discovery Software Market Forecast
10.6 Global AI-Powered Drug Discovery Software Forecast by Type (2025-2030)
10.7 Global AI-Powered Drug Discovery Software Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 AtomWise
11.1.1 AtomWise Company Information
11.1.2 AtomWise AI-Powered Drug Discovery Software Product Offered
11.1.3 AtomWise AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AtomWise Main Business Overview
11.1.5 AtomWise Latest Developments
11.2 AutoDock
11.2.1 AutoDock Company Information
11.2.2 AutoDock AI-Powered Drug Discovery Software Product Offered
11.2.3 AutoDock AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AutoDock Main Business Overview
11.2.5 AutoDock Latest Developments
11.3 BenevolentAI
11.3.1 BenevolentAI Company Information
11.3.2 BenevolentAI AI-Powered Drug Discovery Software Product Offered
11.3.3 BenevolentAI AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 BenevolentAI Main Business Overview
11.3.5 BenevolentAI Latest Developments
11.4 CCD Vault
11.4.1 CCD Vault Company Information
11.4.2 CCD Vault AI-Powered Drug Discovery Software Product Offered
11.4.3 CCD Vault AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CCD Vault Main Business Overview
11.4.5 CCD Vault Latest Developments
11.5 Compound Assist
11.5.1 Compound Assist Company Information
11.5.2 Compound Assist AI-Powered Drug Discovery Software Product Offered
11.5.3 Compound Assist AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Compound Assist Main Business Overview
11.5.5 Compound Assist Latest Developments
11.6 Cyclica
11.6.1 Cyclica Company Information
11.6.2 Cyclica AI-Powered Drug Discovery Software Product Offered
11.6.3 Cyclica AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Cyclica Main Business Overview
11.6.5 Cyclica Latest Developments
11.7 DrugDev Spark
11.7.1 DrugDev Spark Company Information
11.7.2 DrugDev Spark AI-Powered Drug Discovery Software Product Offered
11.7.3 DrugDev Spark AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 DrugDev Spark Main Business Overview
11.7.5 DrugDev Spark Latest Developments
11.8 DrugPatentWatch
11.8.1 DrugPatentWatch Company Information
11.8.2 DrugPatentWatch AI-Powered Drug Discovery Software Product Offered
11.8.3 DrugPatentWatch AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 DrugPatentWatch Main Business Overview
11.8.5 DrugPatentWatch Latest Developments
11.9 DSG Drug Safety
11.9.1 DSG Drug Safety Company Information
11.9.2 DSG Drug Safety AI-Powered Drug Discovery Software Product Offered
11.9.3 DSG Drug Safety AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 DSG Drug Safety Main Business Overview
11.9.5 DSG Drug Safety Latest Developments
11.10 Epocrates
11.10.1 Epocrates Company Information
11.10.2 Epocrates AI-Powered Drug Discovery Software Product Offered
11.10.3 Epocrates AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Epocrates Main Business Overview
11.10.5 Epocrates Latest Developments
11.11 InSilicoTrials
11.11.1 InSilicoTrials Company Information
11.11.2 InSilicoTrials AI-Powered Drug Discovery Software Product Offered
11.11.3 InSilicoTrials AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 InSilicoTrials Main Business Overview
11.11.5 InSilicoTrials Latest Developments
11.12 Insilico Medicine
11.12.1 Insilico Medicine Company Information
11.12.2 Insilico Medicine AI-Powered Drug Discovery Software Product Offered
11.12.3 Insilico Medicine AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Insilico Medicine Main Business Overview
11.12.5 Insilico Medicine Latest Developments
11.13 Micro Tracker
11.13.1 Micro Tracker Company Information
11.13.2 Micro Tracker AI-Powered Drug Discovery Software Product Offered
11.13.3 Micro Tracker AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Micro Tracker Main Business Overview
11.13.5 Micro Tracker Latest Developments
11.14 PEPID PDC
11.14.1 PEPID PDC Company Information
11.14.2 PEPID PDC AI-Powered Drug Discovery Software Product Offered
11.14.3 PEPID PDC AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 PEPID PDC Main Business Overview
11.14.5 PEPID PDC Latest Developments
11.15 厂肠丑谤枚诲颈苍驳别谤
11.15.1 厂肠丑谤枚诲颈苍驳别谤 Company Information
11.15.2 厂肠丑谤枚诲颈苍驳别谤 AI-Powered Drug Discovery Software Product Offered
11.15.3 厂肠丑谤枚诲颈苍驳别谤 AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 厂肠丑谤枚诲颈苍驳别谤 Main Business Overview
11.15.5 厂肠丑谤枚诲颈苍驳别谤 Latest Developments
11.16 Thermo Scientific
11.16.1 Thermo Scientific Company Information
11.16.2 Thermo Scientific AI-Powered Drug Discovery Software Product Offered
11.16.3 Thermo Scientific AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Thermo Scientific Main Business Overview
11.16.5 Thermo Scientific Latest Developments
11.17 XtalPi
11.17.1 XtalPi Company Information
11.17.2 XtalPi AI-Powered Drug Discovery Software Product Offered
11.17.3 XtalPi AI-Powered Drug Discovery Software Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 XtalPi Main Business Overview
11.17.5 XtalPi Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂